These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38385787)
1. Effect of Laryngopharyngeal Reflux and Potassium-Competitive Acid Blocker (P-CAB) on the Microbiological Comprise of the Laryngopharynx. Zheng X; Zheng Y; Chen T; Hou C; Zhou L; Liu C; Zheng J; Hu R Otolaryngol Head Neck Surg; 2024 May; 170(5):1380-1390. PubMed ID: 38385787 [TBL] [Abstract][Full Text] [Related]
2. Analysis on the pharyngeal microbiota in patients with laryngopharyngeal reflux disease. Zhang J; Fan X Braz J Otorhinolaryngol; 2023; 89(6):101331. PubMed ID: 37782990 [TBL] [Abstract][Full Text] [Related]
3. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets. Li Y; Xu G; Zhou B; Tang Y; Liu X; Wu Y; Wang Y; Kong J; Xu T; He C; Zhu S; Wang X; Zhang J Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2743-2752. PubMed ID: 34860271 [TBL] [Abstract][Full Text] [Related]
4. Distinct microbiota dysbiosis in patients with laryngopharynx reflux disease compared to healthy controls. Chen H; Wang H; Yang F; Wang M; Chen X Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3569-3579. PubMed ID: 35394189 [TBL] [Abstract][Full Text] [Related]
5. Salivary microbiota composition before and after use of proton pump inhibitors in patients with laryngopharyngeal reflux: a self-control study. Cui X; Yin L; Zhang Y; Jiang X; Li L; Bi X BMC Oral Health; 2024 Oct; 24(1):1194. PubMed ID: 39379876 [TBL] [Abstract][Full Text] [Related]
6. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease]. Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386 [No Abstract] [Full Text] [Related]
7. [Effect of gastroesophageal reflux disease on the clinical characteristics of patients with laryngopharyngeal reflux disease]. Wang XY; Li JR; Zhang JH; Wang JS; Liu Z; Zhang C Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1178-1184. PubMed ID: 36319122 [No Abstract] [Full Text] [Related]
8. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease. Lin RJ; Sridharan S; Smith LJ; Young VN; Rosen CA Laryngoscope; 2018 Jan; 128(1):133-137. PubMed ID: 28730666 [TBL] [Abstract][Full Text] [Related]
9. Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction. Wang AM; Wang G; Huang N; Zheng YY; Yang F; Qiu X; Chen XM Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2283-2287. PubMed ID: 31177327 [TBL] [Abstract][Full Text] [Related]
11. LPR: how different diagnostic tools shape the outcomes of treatment. Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501 [TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of pepsin in the diagnosis of laryngopharyngeal reflux disease]. Wang X; Chen W; Wang QP Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 May; 31(9):728-731. PubMed ID: 29871361 [TBL] [Abstract][Full Text] [Related]
14. Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study. Lechien JR Otolaryngol Head Neck Surg; 2024 Oct; 171(4):1114-1122. PubMed ID: 38961817 [TBL] [Abstract][Full Text] [Related]
15. Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux. Wang CP; Wang CC; Lien HC; Lin WJ; Wu SH; Liang KL; Liu SA Laryngoscope; 2019 Mar; 129(3):709-714. PubMed ID: 30247754 [TBL] [Abstract][Full Text] [Related]
16. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial. Shen H; Han Y; Wu D; Hu L; Ma Y; Wu F; Tao Y; Liu Y Trials; 2022 Apr; 23(1):272. PubMed ID: 35395946 [TBL] [Abstract][Full Text] [Related]
17. [The prevalence and relationship between laryngopharyngeal reflux disease, anxiety and depression in otolaryngology outpatients]. Li CF; Zhang LH; Wang WL; Cao J; Wang YG; Zhao YX Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Mar; 55(3):241-248. PubMed ID: 32268693 [No Abstract] [Full Text] [Related]
18. Expression of CAIII and Hsp70 Is Increased the Mucous Membrane of the Posterior Commissure in Laryngopharyngeal Reflux Disease. Min HJ; Hong SC; Yang HS; Mun SK; Lee SY Yonsei Med J; 2016 Mar; 57(2):469-74. PubMed ID: 26847302 [TBL] [Abstract][Full Text] [Related]
19. Different cutoffs of the reflux finding score for diagnosing laryngopharyngeal reflux disease should be used for different genders. Gao CK; Li YF; Wang L; Han XY; Wu T; Zeng FF; Li XP Acta Otolaryngol; 2018 Sep; 138(9):848-854. PubMed ID: 29852801 [TBL] [Abstract][Full Text] [Related]
20. Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease. Cui N; Dai T; Liu Y; Wang YY; Lin JY; Zheng QF; Zhu DD; Zhu XW World J Gastroenterol; 2024 Apr; 30(16):2209-2219. PubMed ID: 38690022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]